Integer (NYSE:ITGR – Free Report) had its price objective increased by Benchmark from $105.00 to $130.00 in a report issued on Thursday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock. A number of other equities research analysts have also recently issued reports on ITGR. KeyCorp decreased their target price […]